Area:
addiction/cognition
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Deanna L. Wallace is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 2009 — 2011 |
Wallace, Deanna |
F32Activity Code Description:
To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in specified health-related areas. |
The Effects of Dopamine On Components of Working Memory. @ University of California Berkeley
DESCRIPTION (provided by applicant): This project is directed towards understanding the relationship between dopamine (DA) and higher cognitive function, including working memory (WM) and executive control. The effects of DA agonists on tasks that depend on these higher cognitive functions will be explored in healthy human subjects with varying degrees of WM capacity. The relationship between dopamine and WM is complex, with the effects of DA agonists depending on baseline WM capacity. This relationship will be investigated using functional magnetic resonance imaging (fMRI) in healthy young individuals after the administration of a dopamine agonist to study the role of DA in cognitive efficiency and top-down modulation. As part of a larger study, positron emission tomography (PET) neurochemical imaging will also be utilized to study pharmacological mechanisms underlying these effects of DA on cognition. DA is of fundamental importance to the etiology of a wide variety of neurobehavioral disorders such as Parkinson's disease, attention deficit hyperactivity disorder, schizophrenia and drug addiction. A further understanding of the relationship between DA and cognition should advance our understanding of the mechanisms underlying cognitive and behavioral deficits in these disorders and provide insight into novel approaches to treating such deficits with medications targeted at specific neurotransmitter systems.
|
0.915 |